COOK Medical, one of Limerick’s biggest employers, is to invest €16.5m at its Plassey operation over the next four years.
The company, which currently employs 630 people at the National Technology Park, has announced that it will invest in a new high-tech research and development laboratory, with support from the government.
The move will see a small number of technical engineering jobs created, with the laboratory allowing for enhanced collaboration with doctors and physicians.
Since it opened in Limerick in 1996, Cook has manufactured high-tech medical devices, including the Zilver PTX drug eluding stent, which treat arterial diseases.
Now, with the support of the IDA, the company will be able to carry out research into further ground-breaking medical devices.
Executive vice president of Cook Ireland Bill Doherty said this “raises the bar,” allowing the company to explore the development of Class Three medical devices, which among other things, support human life, and are of substantial importance in preventing the impairment of human health.
Cook Medical is to supply directly to doctors in Irish hospitals, a move which will allow a direct connection with the research facility.
Mr Doherty said: “By selling direct, Cook Medical is able to focus on clinical needs and patient outcomes in a cost-effective manner. We are looking forward to sharing the wealth of product and business knowledge that sits in Cook Ireland, with physicians and procurement teams around the country, as we strive for better patient outcomes in this dynamic yet pressured health sector.”